Estimauville life sciences hub

A cutting-edge environment dedicated to scientific advances, applied research, and technological development.

Formerly known as Medicago, the building was initially designed for the production of 40 to 50 million doses of seasonal flu vaccines. It also housed corporate offices as well as research and development activities.

The building has since changed hands and purpose. It now positions itself as a life sciences hub, aiming to create a state-of-the-art environment dedicated to scientific and technological advancements, and to meet the growing needs of the health and life sciences sectors. The building offers modern, flexible, and highly specialized infrastructure, fostering innovation, applied research, and high-value industrial development.

Given its scale and new mission, the project actively contributes to strengthening Quebec City's health ecosystem. It supports regional influence by positioning Quebec as a centre of excellence in the life sciences and health technologies, both nationally and internationally.

The first tenants moved in as early as October 2025. The building continues to evolve with the gradual arrival of new companies, supporting a diverse range of scientific, industrial, and technological activities while fostering collaboration among innovation stakeholders.